When Donald Hayden, a 25-year veteran of Bristol-Myers Squibb, joined WindMIL Therapeutics as its executive chairman, he figured he would steer the ship until the company’s board picked a permanent ...
Inside FastForward 1812, an East Baltimore-based incubator home that is based in East Baltimore. Johns Hopkins spinout WindMIL Therapeutics is opening a new office in Philadelphia as the biotech ...
BALTIMORE--(BUSINESS WIRE)--WindMIL Therapeutics, a clinical stage company developing Marrow-Infiltrating Lymphocytes (MILs™) for cancer immunotherapy, today announced the completion of a $32.5 ...
Kimberly Noonan, PhD, MPH, WindMIL Therapeutics, Co-Founder and Executive Vice President, Chief Science & Technology Officer Kimberly Noonan, PhD, MPH, WindMIL Therapeutics, Co-Founder and Executive ...
WindMIL Therapeutics, a Baltimore-based company specializing in cell therapy to treat cancer, closed on $32.5 million in Series B funding, the company announced on Monday. Currently, the company is ...
BALTIMORE and PHILADELPHIA, Feb. 05, 2020 (GLOBE NEWSWIRE) -- WindMIL Therapeutics, a clinical-stage company developing marrow-infiltrating lymphocytes (MILs™) for cancer immunotherapy, today ...
PHILADELPHIA and BALTIMORE, April 21, 2020 (GLOBE NEWSWIRE) -- WindMIL Therapeutics, a clinical-stage company developing marrow-infiltrating lymphocytes (MILs™) for cancer immunotherapy, today ...
BALTIMORE and PHILADELPHIA, Nov. 06, 2019 (GLOBE NEWSWIRE) -- WindMIL Therapeutics, a clinical-stage company developing marrow-infiltrating lymphocytes (MILs™) for cancer immunotherapy, announced ...
PHILADELPHIA and BALTIMORE, Sept. 03, 2020 (GLOBE NEWSWIRE) -- WindMIL Therapeutics, a clinical-stage company developing marrow-infiltrating lymphocyte (MILs™) products for cancer immunotherapy, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback